After reaching a $6.01 billion deal with 3M to settle the largest mass tort litigation in U.S. history, lawyers for the ...

Diversified products maker 3M India reported its first drop in quarterly profit in three years on Tuesday, pressured by ...

Oppenheimer raised the firm’s price target on Tarsus Pharmaceuticals (TARS) to $65 from $63 and keeps an Outperform rating on the shares.

Merck-Sharp and Dohme), screening for HPV (Digene Corp.), and HPV therapy (3M Pharmaceuticals). Eduardo Franco has served as an occasional paid consultant to pharmaceutical and biotechnology ...

Bruce, Professional Relations Associate, 3M Pharmaceuticals, personal communication, March 2007). Of interest to us were the four subjects (15%) with reactions to fragrance mix. The positive ...

3M Co.’s new chief is recalling managers to the office, dialing back a remote-friendly policy that his predecessor had hailed as being “rooted in flexibility and trust.” The industrial giant ...

The Company's full financial statements and related MD&A for the first quarter ended September 30, 2024, are available at www.inmedpharma.com, www.sedar.com and at www.sec.gov.

The United States Agency for International Development has announced a $2.3m commitment to procure 4.8 million doses of ...

Third Quarter 2024 Results Key Financial Results Revenue: US$33.3m (up 48% ...

Revenue exceeded analyst estimates by 2.7%. Earnings per share (EPS) missed analyst estimates significantly. Looking ahead, ...

Community Health Network is suing insurer Humana Inc., claiming the Louisville company owes it $7.4 million in drugs for its ...

Reports Q3 revenue $148.3M, consensus $144.35M ... Try Now>> See today’s best-performing stocks on TipRanks >> Read More on ANIP: Biosante Pharmaceuticals NewsMORE Related Stocks Indices Commodities ...